Aldehyde Dehydrogenase 1 Identifies Cells with Cancer Stem Cell-Like Properties in a Human Renal Cell Carcinoma Cell Line

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Ueda, Kosuke ^a   Ogasawara, Sachiko ^a   Akiba, Jun ^a   Nakayama, Masamichi ^a   Todoroki, Keita ^a   Ueda, Keiko ^a   Sanada, Sakiko ^a   Suekane, Shigetaka ^a   Noguchi, Masanori ^a   Matsuoka, Kei ^a   Yano, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; MESSENGER RNA; SORAFENIB; UNCLASSIFIED DRUG;

ABC TRANSPORTER GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTI APOPTOSIS GENE; ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CANCER STEM CELL LIKE CELL; CARCINOGENICITY; CARCINOMA CELL; CELL POPULATION; CELL RENEWAL; CELL STRAIN ACHN; CELL STRAIN KRC Y; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY CARCINOMA; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PROTEIN EXPRESSION; SCID MOUSE; SELF REPLICATION GENE; TUMOR GENE;

CARCINOGENESIS; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; KIDNEY NEOPLASMS; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL;

EID: 84885097671     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075463     Document Type: Article

References (52)

1. Kroeger N, Seligson DB, Klatte T, Rampersaud EN, Birkhauser FD, et al. (2012) Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. Eur Urol 61: 888-895.
2. Costa LJ, Drabkin HA, (2007) Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies. Oncologist 12: 1404-1415.
3. Flanigan RC, Campbell SC, Clark JI, Picken MM, (2003) Metastatic renal cell carcinoma. Curr Treat Options Oncol 4: 385-390.
4. Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, et al. (2007) Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med 356: 115-124.
5. Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, et al. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med 356: 125-134.
6. Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, et al. (2008) Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 372: 449-456.
7. Bonnet D, Dick JE, (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3: 730-737.
8. Nowell PC, (1976) The clonal evolution of tumor cell populations. Science 194: 23-28.
9. Dalerba P, Cho RW, Clarke MF, (2007) Cancer stem cells: models and concepts. Annu Rev Med 58: 267-284.
10. Visvader JE, Lindeman GJ, (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768.
11. Bussolati B, Bruno S, Grange C, Ferrando U, Camussi G, (2008) Identification of a tumor-initiating stem cell population in human renal carcinomas. FASEB J 22: 3696-3705.
12. Bussolati B, Brossa A, Camussi G, (2011) Resident stem cells and renal carcinoma. Int J Nephrol 2011: 286985.
13. Kim K, Ro JY, Kim S, Cho YM, (2012) Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma. Hum Pathol 43: 2109-2116.
14. Kim K, Ihm H, Ro JY, Cho YM, (2011) High-level expression of stem cell marker CD133 in clear cell renal cell carcinoma with favorable prognosis. Oncol Lett 2: 1095-1100.
15. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, et al. (2004) A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 101: 14228-14233.
16. Hulspas R, Quesenberry PJ, (2000) Characterization of neurosphere cell phenotypes by flow cytometry. Cytometry 40: 245-250.
17. Addla SK, Brown MD, Hart CA, Ramani VA, Clarke NW, (2008) Characterization of the Hoechst 33342 side population from normal and malignant human renal epithelial cells. Am J Physiol Renal Physiol 295: F680-687.
18. Nishizawa S, Hirohashi Y, Torigoe T, Takahashi A, Tamura Y, et al. (2012) HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells. Cancer Res 72: 2844-2854.
19. Kondo T, Setoguchi T, Taga T, (2004) Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 101: 781-786.
20. Loebinger MR, Giangreco A, Groot KR, Prichard L, Allen K, et al. (2008) Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Br J Cancer 98: 380-387.
21. Ikeda K, Saitoh S, Arase Y, Chayama K, Suzuki Y, et al. (1999) Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29: 1124-1130.
22. Marcato P, Dean CA, Pan D, Araslanova R, Gillis M, et al. (2011) Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29: 32-45.
23. Resetkova E, Reis-Filho JS, Jain RK, Mehta R, Thorat MA, et al. (2010) Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 123: 97-108.
24. Huang CP, Tsai MF, Chang TH, Tang WC, Chen SY, et al. (2012) ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Cancer Lett 328: 144-151.
25. Ozbek E, Calik G, Otunctemur A, Aliskan T, Cakir S, et al. (2012) Stem cell markers aldehyde dehydrogenase type 1 and nestin expressions in renal cell cancer. Arch Ital Urol Androl 84: 7-11.
26. Yano H, Maruiwa M, Sugihara S, Kojiro M, Noda S, et al. (1988) Establishment and characterization of a new human renal cell carcinoma cell line (KRC/Y). In Vitro Cell Dev Biol 24: 9-16.
27. Chiba T, Kita K, Zheng YW, Yokosuka O, Saisho H, et al. (2006) Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 44: 240-251.
28. Hisaka T, Yano H, Ogasawara S, Momosaki S, Nishida N, et al. (2004) Interferon-alphaCon1 suppresses proliferation of liver cancer cell lines in vitro and in vivo. J Hepatol 41: 782-789.
29. Lim YC, Oh SY, Cha YY, Kim SH, Jin X, et al. (2011) Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol 47: 83-91.
30. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
31. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC, (1996) Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 183: 1797-1806.
32. Burkert J, Otto WR, Wright NA, (2008) Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol 214: 564-573.
33. Takaishi S, Okumura T, Tu S, Wang SS, Shibata W, et al. (2009) Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27: 1006-1020.
34. Broadley KW, Hunn MK, Farrand KJ, Price KM, Grasso C, et al. (2011) Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme. Stem Cells 29: 452-461.
35. Ibrahim SF, Diercks AH, Petersen TW, van den Engh G, (2007) Kinetic analyses as a critical parameter in defining the side population (SP) phenotype. Exp Cell Res 313: 1921-1926.
36. Ooka H, Kanda S, Okazaki H, Suzuki H, Mishima K, et al. (2012) Characterization of side population (SP) cells in murine cochlear nucleus. Acta Otolaryngol 132: 693-701.
37. Goodell MA, Rosenzweig M, Kim H, Marks DF, DeMaria M, et al. (1997) Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 3: 1337-1345.
38. Luo Y, Ellis LZ, Dallaglio K, Takeda M, Robinson WA, et al. (2012) Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance. J Invest Dermatol 132: 2440-2450.
39. Smith PJ, Wiltshire M, Chappell SC, Cosentino L, Burns PA, et al. (2012) Kinetic analysis of intracellular Hoechst 33342-DNA interactions by flow cytometry: Misinterpretation of side population status? Cytometry A 83: 161-169.
40. Ma I, Allan AL, (2011) The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 7: 292-306.
41. Marcato P, Dean CA, Giacomantonio CA, Lee PW, (2011) Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 10: 1378-1384.
42. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, et al. (2008) Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 6: 1146-1153.
43. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, et al. (2009) Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 7: 330-338.
44. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567.
45. Kim MP, Fleming JB, Wang H, Abbruzzese JL, Choi W, et al. (2011) ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. PLoS One 6: e20636.
46. van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Lippitt JM, et al. (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70: 5163-5173.
47. Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, et al. (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232-239.
48. Paez-Ribes M, Allen E, Hudock J, Takeda T, Okuyama H, et al. (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15: 220-231.
49. Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, et al. (2012) Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A 109: 2784-2789.
50. Yajima T, Ochiai H, Uchiyama T, Takano N, Shibahara T, et al. (2009) Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1. Int J Oncol 35: 273-280.
51. Borovski T, De Sousa EMF, Vermeulen L, Medema JP, (2012) Cancer stem cell niche: the place to be. Cancer Res 71: 634-639.
52. Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN, (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8: 3274-3284.